Stryker Declares $0.75 Quarterly Dividend; 1.1% Yield
Stryker (NYSE:SYK) declared a quarterly dividend of $0.75 per share, or $3 annualized.The dividend will be payable on July 31, 2023, to stockholders of record on June 30, 2023, with an...
-
-
Strong Sales and Momentum Propel Stryker to Stellar Q1 Results: Analysts Keep a Watchful Eye on Future Profitability
Stryker Corporation (NYSE: SYK) reported Q1 sales of $4.80 billion, up 11.8% Y/Y (+14% in constant currency), beating the consensus of $4.56 billion. Adjusted EPS came in at $2.14, which...
-
Stryker raises FY outlook but shares still drop; analysts raise numbers
Stryker (NYSE:SYK) shares trade over 4% lower in pre-open Tuesday after the surgical equipment maker reported its Q1 results and offered guidance. Stryker {{erl-8186||reported EPS of...
-
Barclays maintains Stryker at Overweight, PT $321.00
A Barclays analyst maintained Stryker (NYSE: SYK) at Overweight and a price target of $321.00 from a prior price target of $314.00. Prior to this rating, Stryker had 13 buy ratings, 11...
-
Stryker earnings beat by $0.13, revenue topped estimates
Investing.com - Stryker (NYSE: SYK) reported first quarter EPS of $2.14, $0.13 better than the analyst estimate of $2.01. Revenue for the quarter came in at $4.8B versus the consensus...
-
Medical Alternating Pressure Mattress Market Report | Stryker Corporation, Apex Medical Corp., Hill-Rom Holdings Inc., Paramount Bed Co. Ltd., and Carilex Medical
Newark, New Castle, USA, April 26, 2023 (GLOBE NEWSWIRE) -- According to a recent Growth Plus Reports assessment, the Medical Alternating Pressure Mattress Market is estimated to reach...
-
Truist Securities maintains Stryker at Hold
A Truist Securities analyst maintained Stryker (NYSE: SYK) at Hold and a price target of $300.00 from a prior price target of $275.00. Prior to this rating, Stryker had 14 buy ratings, 11...
-
Barclays maintains Stryker at Overweight
A Barclays analyst maintained Stryker (NYSE: SYK) at Overweight and a price target of $314.00 from a prior price target of $283.00. Prior to this rating, Stryker had 16 buy ratings, 13...
-
Jefferies maintains Stryker at Buy
A Jefferies analyst maintained Stryker (NYSE: SYK) at Buy and a price target of $320.00 from a prior price target of $292.00. Prior to this rating, Stryker had 14 buy ratings, 11 hold...
-
UBS new coverage Stryker Neutral
An UBS analyst initiated new coverage Stryker (NYSE: SYK) Neutral rating and a price target of $287.00. Prior to this rating, Stryker had 14 buy ratings, 10 hold ratings, and 2 sell...
-
After-hours movers: Snap and Match sink on weak outlooks, AMD gains on EPS
After-Hours Stock Movers: Snap (NYSE:SNAP) 13% LOWER; reported Q4 EPS of $0.14, $0.03 better than the analyst estimate of $0.11. {{erl-996528||Revenue for the quarter came in at $1.3...
-
Stryker earnings beat by $0.16, revenue topped estimates
Investing.com - Stryker (NYSE: SYK) reported fourth quarter EPS of $3.00, $0.16 better than the analyst estimate of $2.84. Revenue for the quarter came in at $5.2B versus the consensus...
-
Fed meeting, Exxon record, Eurozone skirts recession - what's moving markets
By Geoffrey Smith Investing.com -- The Federal Reserve starts a two-day policy meeting against a backdrop of weakening economic data - although the International Monetary Fund has raised its...
-
In case you missed it, 10 big dividend hikes: Carrier Global raises by 23%
Here are the biggest fresh dividend hikes and special dividends, as first covered on InvestingPro+, including several predicted by data from InvestingPro+ and StreetInsider this month. Get a...
-
8 dividend hikes to watch for this week: Pfizer, Union Pacific
Companies often establish a pattern of hiking dividends at the same time each year, giving investors a reliable cash influx and enticing them to stick around for the long term. With help...
-
Dow Futures Little Changed After Negative Session
By Oliver Gray Investing.com - U.S. stock futures were trading slightly higher during Monday’s evening deals, after major benchmark indices finished the regular session lower as investors...
-
After-Hours Stock Movers: Hologic, Avis Gain on Results; Goodyear Falls
After-Hours Stock Movers: Varonis Systems (NASDAQ:VRNS) 16% LOWER; reported Q3 EPS of $0.06, in-line with the analyst estimate of $0.06. {{erl-100233||Revenue for the quarter came in at...
-
Stryker Beats on Revenue, But Misses on EPS
By Liz Moyer Investing.com -- Stryker (SYK) reported mixed results for the third quarter. Earnings per share of $2.12 fell short of estimates for earnings of $2.23 a share. Revenue for the...
-
Stryker Beats on Revenue, But Misses on EPS
By Liz Moyer Investing.com -- Stryker (NYSE:SYK) reported mixed results for the third quarter. Earnings per share of $2.12 {{erl-8186||fell short of estimates for earnings of $2.23 a...
-
Stryker Earnings miss, Revenue beats In Q3
Investing.com - Stryker (NYSE:SYK) reported on Monday third quarter {{erl-8186||earnings that missed analysts' forecasts and revenue that topped expectations. Stryker announced earnings...
-
Stryker Misses Q3 EPS by 11c, Updates FY Guidance
Stryker (SYK) reported Q3 EPS of $2.12, $0.11 worse than the analyst estimate of $2.23. Revenue for the quarter came in at $4.5 billion versus the consensus estimate of $4.47...
-
US Earnings to Watch: Pfizer, Qualcomm, CVS, Peloton, Coinbase, Uber
(Bloomberg) -- Alphabet’s earnings misses, and disappointing forecasts last week from Amazon (NASDAQ:AMZN) and Meta Platforms (NASDAQ:META) exposed tech giants’ vulnerability to a slowing...
-
Tesla-Glencore Talks, Russia Grain Deal, Lula Victory - What's Moving Markets
By Geoffrey Smith Investing.com -- Tesla eyes radical steps to lock in supplies of key battery metals, while Apple's main supplier is scrambling to relocate staff away from its biggest...
-
Stryker Earnings, Revenue miss In Q2
Investing.com - Stryker (NYSE:SYK) reported on Tuesday second quarter {{erl-8186||earnings that missed analysts' forecasts and revenue that fell short of expectations. Stryker announced...
-
Stryker Misses Q2 EPS by 3c, Updates Guidance
Stryker (NYSE:SYK) reported Q2 EPS of $2.25, $0.03 worse than the analyst estimate of $2.28. Revenue for the quarter came in at $4.5 billion versus the consensus estimate of $4.54...
-
Top 5 Things to Watch in Markets in the Week Ahead - Fed Rate Hike, Earnings Flood
By Daniel Shvartsman Investing.com - Central Banks and earnings will continue to dominate the week ahead. After the European Central Bank announced an unexpectedly hawkish 50 basis point...
-
Stryker Earnings miss, Revenue beats In Q1
Investing.com - Stryker (NYSE:SYK) reported on Thursday first quarter {{erl-8186||earnings that missed analysts' forecasts and revenue that topped expectations. Stryker announced...
-
Stryker Tops Q1 EPS by 2c
Stryker (NYSE:SYK) reported Q1 EPS of $1.97, $0.02 better than the analyst estimate of $1.95. Revenue for the quarter came in at $4.3 billion versus the consensus estimate of $4.18...
-
Midday Stock Movers: Stryker and Mullen Automotive Hit by Short Reports
By Sam Boughedda Investing.com -- U.S. stock indices are down once again Wednesday, with the Nasdaq decreasing 2.4% and the S&P 500 declining 1.22%. Here are the midday movers on Wednesday,...
-
Stryker Shares Slide After Spruce Point Capital Releases Short Report
By Sam Boughedda Investing.com -- Medical technology firm Stryker Corporation (NYSE:SYK) saw its shares fall significantly at the open on Wednesday after short-selling firm Spruce Point...
-
Wall Street Opens Lower, Hurt by Rising Bond Yields; Dow Down 280 Pts
By Geoffrey Smith Investing.com -- U.S. stock markets opened lower again on Wednesday, extending the losses that they posted on Tuesday in response to warning words from Lael Brainard and...
-
Stryker Earnings miss, Revenue beats In Q4
Investing.com - Stryker (NYSE:SYK) reported on Thursday fourth quarter {{erl-8186||earnings that missed analysts' forecasts and revenue that topped expectations. Stryker announced...
-
Stryker To Acquire Vocera In $2.97 Billion Deal
By Sam Boughedda Investing.com — Shares of Vocera Communications Inc (NYSE:VCRA) shot higher Thursday after medical technology company Stryker Corporation (NYSE:SYK) announced a deal...
-
Microbot Medical Surges On Stryker Collaboration
By Sam Boughedda Investing.com — Microbot Medical Inc (NASDAQ:MBOT), the medical device firm, is up nearly 70% to $9.20 Monday morning on news it has inked a deal with Stryker...
-
Stryker Earnings, Revenue miss In Q3
Investing.com - Stryker (NYSE:SYK) reported on Thursday third quarter {{erl-8186||earnings that missed analysts' forecasts and revenue that fell short of expectations. Stryker announced...
-
Stryker Earnings, Revenue beat In Q2
Investing.com - Stryker (NYSE:SYK) reported on Tuesday second quarter {{erl-8186||earnings that beat analysts' forecasts and revenue that topped expectations. Stryker announced earnings...
-
Stryker Earnings miss, Revenue Inline In Q1
Investing.com - Stryker (NYSE:SYK) reported on Tuesday first quarter {{erl-8186||earnings that missed analysts' forecasts and revenue that was inline with expectations. Stryker announced...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
